Lung cancer risk and occupational pulmonary fibrosis: systematic review and meta-analysis
- PMID: 38355151
- PMCID: PMC10865097
- DOI: 10.1183/16000617.0224-2023
Lung cancer risk and occupational pulmonary fibrosis: systematic review and meta-analysis
Abstract
Background: Molecular pathways found to be important in pulmonary fibrosis are also involved in cancer pathogenesis, suggesting common pathways in the development of pulmonary fibrosis and lung cancer.
Research question: Is pulmonary fibrosis from exposure to occupational carcinogens an independent risk factor for lung cancer?
Study design and methods: A comprehensive search of PubMed, Embase, Web of Science and Cochrane databases with over 100 search terms regarding occupational hazards causing pulmonary fibrosis was conducted. After screening and extraction, quality of evidence and eligibility criteria for meta-analysis were assessed. Meta-analysis was performed using a random-effects model.
Results: 52 studies were identified for systematic review. Meta-analysis of subgroups identified silicosis as a risk factor for lung cancer when investigating odds ratios for silicosis in autopsy studies (OR 1.47, 95% CI 1.13-1.90) and for lung cancer mortality in patients with silicosis (OR 3.21, 95% CI 2.67-3.87). Only considering studies with an adjustment for smoking as a confounder identified a significant increase in lung cancer risk (OR 1.58, 95% CI 1.34-1.87). However, due to a lack of studies including cumulative exposure, no adjustments could be included. In a qualitative review, no definitive conclusion could be reached for asbestosis and silicosis as independent risk factors for lung cancer, partly because the studies did not take cumulative exposure into account.
Interpretation: This systematic review confirms the current knowledge regarding asbestosis and silicosis, indicating a higher risk of lung cancer in exposed individuals compared to exposed workers without fibrosis. These individuals should be monitored for lung cancer, especially when asbestosis or silicosis is present.
Copyright ©The authors 2024.
Conflict of interest statement
Conflict of interest: T. Kraus and J. Krabbe give talks on this topic at workshops, seminars, and conferences for which have been paid for by the organisers including travel and accommodation. J. Krabbe, S. Drießen and T. Kraus have done research in the past funded by German institutions for statutory accident insurance and prevention with unrestricted grants to the University Hospital RWTH Aachen. K.M. Steffens has nothing to disclose.
Figures



Similar articles
-
Risk characterization for silica-related silicosis and lung cancer in communities adjacent to sand and gravel extraction facilities: examining limitations in our current risk methods.Front Public Health. 2025 Jun 18;13:1558778. doi: 10.3389/fpubh.2025.1558778. eCollection 2025. Front Public Health. 2025. PMID: 40606098 Free PMC article.
-
Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD002835. doi: 10.1002/14651858.CD002835.pub3. Cochrane Database Syst Rev. 2007. PMID: 17253483 Free PMC article.
-
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100. Epidemiol Prev. 2013. PMID: 23851286 Italian.
-
Inhaled mannitol for cystic fibrosis.Cochrane Database Syst Rev. 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2020 May 1;5:CD008649. doi: 10.1002/14651858.CD008649.pub4. PMID: 29424930 Free PMC article. Updated.
-
Interventions targeted at women to encourage the uptake of cervical screening.Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3. Cochrane Database Syst Rev. 2021. PMID: 34694000 Free PMC article.
Cited by
-
One-year mortality risk prediction model for patients with interstitial lung disease and lung cancer.Transl Lung Cancer Res. 2025 May 30;14(5):1786-1803. doi: 10.21037/tlcr-2025-235. Epub 2025 May 22. Transl Lung Cancer Res. 2025. PMID: 40535074 Free PMC article.
-
The probability of lung cancer in patients with pulmonary nodules detected via low-dose computed tomography screening in China.BMC Cancer. 2025 Jul 1;25(1):1058. doi: 10.1186/s12885-025-14449-6. BMC Cancer. 2025. PMID: 40597901 Free PMC article.
-
Huaxian formula alleviates nickel oxide nanoparticle-induced pulmonary fibrosis via PI3K/AKT signaling.Sci Rep. 2025 May 22;15(1):17862. doi: 10.1038/s41598-025-01899-y. Sci Rep. 2025. PMID: 40404681 Free PMC article.
-
A comprehensive retrospect on the current perspectives and future prospects of pneumoconiosis.Front Public Health. 2025 Jan 10;12:1435840. doi: 10.3389/fpubh.2024.1435840. eCollection 2024. Front Public Health. 2025. PMID: 39866352 Free PMC article. Review.
-
Malignancy in Systemic Sclerosis: A Multicenter Retrospective Study.Biomedicines. 2025 Apr 19;13(4):993. doi: 10.3390/biomedicines13040993. Biomedicines. 2025. PMID: 40299685 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical